by John P. Hussman, Ph.D | Nov 16, 2020 | alerts, Hussman Funds, Markets/Economy
John P. Hussman, Ph.D. President, Hussman Investment Trust November 2020 The one reality that you can never change is that a higher-priced asset will produce a lower return than a lower-priced asset. You can’t have your cake and eat it. You can enjoy it now, or...
by Paul Lengemann, BullsnBears Economist | Nov 15, 2020 | alerts, Markets/Economy
The University of Michigan’s consumer sentiment decreased to 77 in November from 81.8 in October, a preliminary estimate showed. It is the lowest reading since August as consumers judged future economic prospects less favorably, while their assessments of...
by Michael Markowski | Nov 14, 2020 | alerts, Markets/Economy
Article edited on 11/15/2020 The stock market rally after Pfizer announced that its Coronavirus vaccine had 90% efficacy was premature since the vaccine: Now in stage 3 clinical trials has been fast tracked by FDA for emergency use ONLY Must finish Stage 3 and also...
by Lance Roberts | Nov 14, 2020 | alerts, Markets/Economy, Real Investment Advice
In this issue of “Market Breaks Out On Vaccine Hopes As Cases Surge.” Market Breaks Out Barely Vaccine Will Arrive Too Late The “Smart Money” Is Leaving Town Portfolio Positioning Update MacroView: The Fed Will Monetize All Debt Issuance Sector...
by John Mauldin | Nov 13, 2020 | alerts, Markets/Economy, Mauldin Economics
Last week I talked about the polls misleading us. I, for one, didn’t see a high probability of a Biden presidency combined with a Republican Senate. But, pending recounts, legal actions, and some run-off elections, that’s probably what will happen. We will muddle...
by Lance Roberts | Nov 10, 2020 | alerts, Markets/Economy, Real Investment Advice
In Mid-August, I posited a potential bullish run on the S&P index to 3750. For that to occur from the levels we discussed then, several things would have to happen. One of those was a “vaccine.” Yesterday, the market surged higher on news the Pfizer was close to...
